Orchid Pharma Ltd Quarterly Results

Q2 FY26-27 Results Summary

Revenue

The revenue stands at ₹341.27 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.20 per cent from ₹304.17 crore. This corresponds to a year-on-year *(YoY) growth of 14.34 per cent.

Operating Profit

Operating Profit stands at ₹24.14 crore, reflecting a quarter-on-quarter *(QoQ) increase of 72.43 per cent from ₹14.00 crore. This corresponds to a year-on-year *(YoY) growth of 681.23 per cent.

PBDT

PBDT stands at ₹39.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 180.62 per cent from ₹14.24 crore. This corresponds to a year-on-year *(YoY) growth of 309.43 per cent.

Profit Before Tax

Profit Before Tax stands at ₹28.55 crore, reflecting a quarter-on-quarter *(QoQ) increase of 767.78 per cent from ₹3.29 crore. This corresponds to a year-on-year *(YoY) growth of 2,819.05 per cent.

Net Profit

Net Profit stands at ₹28.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 787.89 per cent from ₹3.22 crore. This represents a 3,276.67 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Orchid Pharma Ltd Earnings

CategoryQ2 FY26-27Q2 FY25-26Change %FY25-26FY24-25Change %
Total Revenue341.27298.4614.341,232.78921.9333.72
Expenses317.13295.377.371,206.54804.7549.93
Other Income17.7611.6452.5836.4227.4732.58
Operating Profit24.143.09681.2362.66144.65-56.68
Depreciation11.4110.815.5543.2534.5525.18
Interest3.642.5741.638.9814.54-38.24
Profit Before Tax28.55-1.05-2819.0510.4395.57-89.09
Tax-0.04-0.15-73.330.00-0.09-100.00
Net Profit28.59-0.90-3276.6710.6295.76-88.91
CategoryQ2 FY26-27Q1 FY26-27Change %
Total Revenue341.27304.1712.20
Expenses317.13290.179.29
Other Income17.761.83870.49
Operating Profit24.1414.0072.43
Depreciation11.4110.954.20
Interest3.642.2363.23
Profit Before Tax28.553.29767.78
Tax-0.040.07-157.14
Net Profit28.593.22787.89

Orchid Pharma Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 990Edelweiss Securities27-May-2025

Orchid Pharma Ltd Financial Reports

Data not available.

Orchid Pharma Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Orchid Pharma0.45%3.41%7.77%-3.65%35.89%11.00%
Bliss GVS Pharma-4.22%-3.47%4.79%9.75%116.65%299.75%
SPARC-0.73%-2.96%5.93%-3.38%5.38%39.87%
FDC-0.53%-0.61%10.85%8.11%3.88%-8.46%
Innova Captab-2.12%-4.56%0.03%-10.28%12.09%28.72%
IOL Chemicals-4.09%-4.91%5.44%8.58%51.84%103.85%
Supriya Lifesci.-0.06%-0.18%-26.19%-22.80%-15.31%-16.44%

Orchid Pharma Ltd Corporate Information

Chairman(Non Exe)&Dir(Non-Ind): R G Agarwal
Executive Director & MD: Manish Dhanuka
E D & Wholetime Director: Mridul Dhanuka
Non-Exec & Non-Independent Dir: Arjun Dhanuka
Independent Non Exe. Director: Dharam Vir
Independent Non Exe. Director: Manoj Goyal
Independent Non Exe. Director: Tanu Singla
Independent Non Exe. Director: Shubha Singh
Company Sec. & Compli. Officer: Kapil Dayya

Orchid Pharma Ltd News

No More Data

More